Reversal of azathioprine-induced inhibition of hyperplasia in regenerating liver.
D000284:Administration, Oral; D000818:Animals; D001379:Azathioprine / Q000008:administration & dosage / Q000494:pharmacology*; D001835:Body Weight; D004247:DNA / Q000032:analysis / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D006498:Hepatectomy; D006965:Hyperplasia; D008099:Liver / Q000032:analysis / Q000033:anatomy & histology; D008115:Liver Regeneration / Q000187:drug effects*; D009929:Organ Size; D011506:Proteins / Q000032:analysis; D012313:RNA / Q000032:analysis; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D011506:Proteins; D014316:Tritium; D012313:RNA; D004247:DNA; D001379:Azathioprine; D013936:Thymidine